Medicinal chemist and longtime blogger at Science Derek Lowe
wrote, "(2) I have a report from someone who had a paper already reviewed, accepted, and posted at a Sage journal who received an unexpected communication from a staffer at the publisher. They asked that the paper be revised at this point to replace any of "gender" with "sex" and to delete all mentions of words such as nonbinary, inclusivity, etc. Otherwise, they said that they would pull the paper, citing the provision of
EO 14168 (which is the one going after transgender rights). The faculty member who got this notice was taken aback, since the study that the paper describes was not federally funded in any way (!)...(3) The situation around NIH and NSF study sessions and advisory panels remains
chaotic. I frankly have been unable to put together a coherent picture amid the freezes, cancellations, postponements, and reschedulings that are being reported."
The Guardian wrote, "The National Institutes of Health (NIH)
said that it was reducing the amount of “indirect” medical research funding going to institutions, which will cut spending by $4bn a year. A limit of 15% of grants awarded to institutions will be allowed for associated costs such as buildings, equipment and support staff. This is a major reduction on what was previously allowed under the NIH grant system...Democrats also criticized the decision, which follows a broader freeze on some research grants imposed by the Trump administration."
I don't know what to say.